Topics

Blood test for inflammatory and cell senescence biomarkers may help predict cognitive decline

09:26 EST 11 Feb 2020 | News-Medical.net

In order to provide the best medical care for newly diagnosed Parkinson's disease (PD) patients, a method of predicting their cognitive and motor progression, beyond using purely clinical parameters, would have major implications for their management.

Original Article: Blood test for inflammatory and cell senescence biomarkers may help predict cognitive decline

NEXT ARTICLE

More From BioPortfolio on "Blood test for inflammatory and cell senescence biomarkers may help predict cognitive decline"

Quick Search

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...